BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35956144)

  • 21. First follow-up radiographic response is one of the predictors of local tumor progression and radiation necrosis after stereotactic radiosurgery for brain metastases.
    Sharma M; Jia X; Ahluwalia M; Barnett GH; Vogelbaum MA; Chao ST; Suh JH; Murphy ES; Yu JS; Angelov L; Mohammadi AM
    Cancer Med; 2017 Sep; 6(9):2076-2086. PubMed ID: 28776956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotactic radiosurgery for intracranial hemangiopericytomas: a multicenter study.
    Cohen-Inbar O; Lee CC; Mousavi SH; Kano H; Mathieu D; Meola A; Nakaji P; Honea N; Johnson M; Abbassy M; Mohammadi AM; Silva D; Yang HC; Grills I; Kondziolka D; Barnett GH; Lunsford LD; Sheehan J
    J Neurosurg; 2017 Mar; 126(3):744-754. PubMed ID: 27104850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
    Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
    J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impacts of EGFR-mutation status and EGFR-TKI on the efficacy of stereotactic radiosurgery for brain metastases from non-small cell lung adenocarcinoma: A retrospective analysis of 133 consecutive patients.
    Yomo S; Oda K
    Lung Cancer; 2018 May; 119():120-126. PubMed ID: 29656746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases.
    Chidel MA; Suh JH; Reddy CA; Chao ST; Lundbeck MF; Barnett GH
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):993-9. PubMed ID: 10863070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeat stereotactic radiosurgery for the management of locally recurrent brain metastases.
    Iorio-Morin C; Mercure-Cyr R; Figueiredo G; Touchette CJ; Masson-Côté L; Mathieu D
    J Neurooncol; 2019 Dec; 145(3):551-559. PubMed ID: 31667732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiological Kinetics of Brain Metastases and Clinical Implications for Patients Treated With Stereotactic Radiosurgery.
    Nicholls LW; Pinkham MB; Bernard A; Lusk R; Watkins T; Hall B; Olson S; Foote MC
    Clin Oncol (R Coll Radiol); 2019 Jan; 31(1):34-40. PubMed ID: 30279038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereotactic radiosurgery for melanoma brain metastases: Concurrent immune checkpoint inhibitor therapy associated with superior clinicoradiological response outcomes.
    Shanker MD; Garimall S; Gatt N; Foley H; Crowley S; Le Cornu E; Muscat K; Soon W; Atkinson V; Xu W; Watkins T; Huo M; Foote MC; Pinkham MB
    J Med Imaging Radiat Oncol; 2022 Jun; 66(4):536-545. PubMed ID: 35343063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of radiosurgery for multiple brain metastases.
    Cho KH; Hall WA; Gerbi BJ; Higgins PD
    Neurosurg Focus; 2000 Aug; 9(2):e2. PubMed ID: 16836288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is stereotactic radiosurgery a rational treatment option for brain metastases from small cell lung cancer? A retrospective analysis of 70 consecutive patients.
    Yomo S; Hayashi M
    BMC Cancer; 2015 Mar; 15():95. PubMed ID: 25879433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereotactic radiosurgery for brain metastases: a case-matched study comparing treatment results for patients 80 years of age or older versus patients 65-79 years of age.
    Watanabe S; Yamamoto M; Sato Y; Kawabe T; Higuchi Y; Kasuya H; Yamamoto T; Matsumura A; Barfod BE
    J Neurosurg; 2014 Nov; 121(5):1148-57. PubMed ID: 25061863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Posterior fossa metastases: risk of leptomeningeal disease when treated with stereotactic radiosurgery compared to surgery.
    Siomin VE; Vogelbaum MA; Kanner AA; Lee SY; Suh JH; Barnett GH
    J Neurooncol; 2004; 67(1-2):115-21. PubMed ID: 15072456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing Preoperative With Postoperative Stereotactic Radiosurgery for Resectable Brain Metastases: A Multi-institutional Analysis.
    Patel KR; Burri SH; Asher AL; Crocker IR; Fraser RW; Zhang C; Chen Z; Kandula S; Zhong J; Press RH; Olson JJ; Oyesiku NM; Wait SD; Curran WJ; Shu HK; Prabhu RS
    Neurosurgery; 2016 Aug; 79(2):279-85. PubMed ID: 26528673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcomes of stereotactic radiosurgery in the treatment of patients with metastatic brain tumors.
    Elaimy AL; Mackay AR; Lamoreaux WT; Fairbanks RK; Demakas JJ; Cooke BS; Lee CM
    World Neurosurg; 2011; 75(5-6):673-83. PubMed ID: 21704935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A matched-pair analysis comparing stereotactic radiosurgery with whole-brain radiotherapy for patients with multiple brain metastases.
    El Shafie RA; Celik A; Weber D; Schmitt D; Lang K; König L; Bernhardt D; Höne S; Forster T; von Nettelbladt B; Adeberg S; Debus J; Rieken S
    J Neurooncol; 2020 May; 147(3):607-618. PubMed ID: 32239433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Prognostic Factors for Early Mortality After Stereotactic Radiosurgery for Brain Metastases: a Single Institutional Retrospective Review.
    Bennett EE; Vogelbaum MA; Barnett GH; Angelov L; Chao S; Murphy E; Yu J; Suh JH; Elson P; Stevens GHJ; Mohammadi AM
    Neurosurgery; 2018 Jul; 83(1):128-136. PubMed ID: 28673040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of timing of stereotactic radiosurgery treatment of melanoma brain metastases treated with ipilimumab.
    Cohen-Inbar O; Shih HH; Xu Z; Schlesinger D; Sheehan JP
    J Neurosurg; 2017 Nov; 127(5):1007-1014. PubMed ID: 28059663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treating Brain Metastases from Breast Cancer: Outcomes after Stereotactic Radiosurgery.
    Wilson TG; Robinson T; MacFarlane C; Spencer T; Herbert C; Wade L; Reed H; Braybrooke JP
    Clin Oncol (R Coll Radiol); 2020 Jun; 32(6):390-396. PubMed ID: 32131980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffusion and Perfusion MRI Predicts Response Preceding and Shortly After Radiosurgery to Brain Metastases: A Pilot Study.
    Shah AD; Shridhar Konar A; Paudyal R; Oh JH; LoCastro E; Nuñez DA; Swinburne N; Vachha B; Ulaner GA; Young RJ; Holodny AI; Beal K; Shukla-Dave A; Hatzoglou V
    J Neuroimaging; 2021 Mar; 31(2):317-323. PubMed ID: 33370467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.